Cathelicidin-like Helminth Defence Molecules (HDMs): Absence of Cytotoxic, Anti-microbial and Anti-protozoan Activities Imply a Specific Adaptation to Immune Modulation

PLoS Neglected Tropical Diseases

Volumn 7, Issue 7, 2013, Pages

  Thivierge, Karine ^a,b   Cotton, Sophie ^a   Schaefer, Deborah A ^c   Riggs, Michael W ^c   To, Joyce ^d   Lund, Maria E ^d   Robinson, Mark W ^d,e   Dalton, John P ^a   Donnelly, Sheila M ^d  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; HELMINTH DEFENCE MOLECULES; IMMUNOGLOBULIN G1; LACTATE DEHYDROGENASE; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CALF (BOVINE); CELL ACTIVATION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCIOLA HEPATICA; FUNGAL VIABILITY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PROTEIN SECONDARY STRUCTURE; SCHISTOSOMA MANSONI; SEQUENCE ANALYSIS;

EID: 84880771899     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002307     Document Type: Article

References (106)

1. Hancock RE, Diamond G, (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8: 402-410.
2. Bowdish DM, Davidson DJ, Speert DP, Hancock RE, (2004) The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 172: 3758-3765.
3. Mookherjee N, Hancock RE, (2007) Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64: 922-933.
4. Andes D, Craig W, Nielsen LA, Kristensen HH, (2009) In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrob Agents Chemother 53: 3003-3009.
5. Hsu KH, Pei C, Yeh JY, Shih CH, Chung YC, et al. (2009) Production of bioactive human alpha-defensin 5 in Pichia pastoris. J Gen Appl Microbiol 55: 395-401.
6. Fjell CD, Hancock RE, Cherkasov A, (2007) AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 23: 1148-1155.
7. Zanetti M, (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 39-48.
8. Lehrer RI, (2004) Primate defensins. Nat Rev Microbiol 2: 727-738.
9. Ganz T, (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720.
10. Hancock RE, Chapple DS, (1999) Peptide antibiotics. Antimicrob Agents Chemother 43: 1317-1323.
11. Oppenheim JJ, Yang D, (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17: 359-365.
12. Lai Y, Gallo RL, (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141.
13. Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau HU, et al. (2009) Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci 10: 3951-3970.
14. Choi KY, Mookherjee N, (2012) Multiple immune-modulatory functions of cathelicidin host defense peptides. Front Immunol 3: 149.
15. Allen JE, Maizels RM, (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11: 375-388.
16. Jackson JA, Friberg IM, Little S, Bradley JE, (2009) Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology 126: 18-27.
17. James SL, Glaven J, (1989) Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 143: 4208-4212.
18. Allen JE, Wynn TA, (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7: e1002003.
19. Perrigoue JG, Marshall FA, Artis D, (2008) On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites. Cell Microbiol 10: 1757-1764.
20. Harnett W, Harnett MM, (2010) Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol 10: 278-284.
21. Donnelly S, O'Neill SM, Stack CM, Robinson MW, Turnbull L, et al. (2010) Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem 285: 3383-3392.
22. Dowling DJ, Hamilton CM, Donnelly S, La Course J, Brophy PM, et al. (2010) Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun 78: 793-801.
23. Donnelly S, Stack CM, O'Neill SM, Sayed AA, Williams DL, et al. (2008) Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 22: 4022-4032.
24. Donnelly S, O'Neill SM, Sekiya M, Mulcahy G, Dalton JP, (2005) Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun 73: 166-173.
25. Robinson MW, Donnelly S, Hutchinson AT, To J, Taylor NL, et al. (2011) A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog 7: e1002042.
26. Rao KV, Ramaswamy K, (2000) Cloning and expression of a gene encoding Sm16, an anti-inflammatory protein from Schistosoma mansoni. Mol Biochem Parasitol 108: 101-108.
27. Bagella L, Scocchi M, Zanetti M, (1995) cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett 376: 225-228.
28. Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R, (1999) SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463: 58-62.
29. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, et al. (1997) Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272: 13088-13093.
30. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, et al. (1995) FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92: 195-199.
31. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, et al. (1996) Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271: 28375-28381.
32. Wang G, Li X, Wang Z, (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933-937.
33. Cole C, Barber JD, Barton GJ, (2008) The Jpred 3 secondary structure prediction server. Nucleic Acids Res 36: W197-201.
34. Gautier R, Douguet D, Antonny B, Drin G, (2008) HELIQUEST: a web server to screen sequences with specific alpha-helical properties. Bioinformatics 24: 2101-2102.
35. Wiegand I, Hilpert K, Hancock RE, (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163-175.
36. Heine J, Pohlenz JF, Moon HW, Woode GN, (1984) Enteric lesions and diarrhea in gnotobiotic calves monoinfected with Cryptosporidium species. J Infect Dis 150: 768-775.
37. Riggs MW, McGuire TC, Mason PH, Perryman LE, (1989) Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites. J Immunol 143: 1340-1345.
38. Riggs MW, Perryman LE, (1987) Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect Immun 55: 2081-2087.
39. Arrowood MJ, Sterling CR, (1987) Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol 73: 314-319.
40. Akiyoshi DE, Feng X, Buckholt MA, Widmer G, Tzipori S, (2002) Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species. Infect Immun 70: 5670-5675.
41. Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, et al. (2006) Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 75: 851-857.
42. Akiyoshi DE, Mor S, Tzipori S, (2003) Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets. Infect Immun 71: 5765-5771.
43. Arrowood MJ, Jaynes JM, Healey MC, (1991) In vitro activities of lytic peptides against the sporozoites of Cryptosporidium parvum. Antimicrob Agents Chemother 35: 224-227.
44. Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Scalise G, (2000) Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture. Antimicrob Agents Chemother 44: 3473-3475.
45. Giacometti A, Cirioni O, Del Prete MS, Skerlavaj B, Circo R, et al. (2003) In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides. J Antimicrob Chemother 51: 843-847.
46. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V, (2004) Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 72: 2772-2779.
47. Carryn S, Schaefer DA, Imboden M, Homan EJ, Bremel RD, et al. (2012) Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms. J Parasitol 98: 199-204.
48. Boman HG, (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254: 197-215.
49. Wang G, (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283: 32637-32643.
50. Yu K, Park K, Kang SW, Shin SY, Hahm KS, et al. (2002) Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy. J Pept Res 60: 1-9.
51. Tack BF, Sawai MV, Kearney WR, Robertson AD, Sherman MA, et al. (2002) SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 269: 1181-1189.
52. Rosenfeld Y, Shai Y, (2006) Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758: 1513-1522.
53. Hirsch T, Metzig M, Niederbichler A, Steinau HU, Eriksson E, et al. (2008) Role of host defense peptides of the innate immune response in sepsis. Shock 30: 117-126.
54. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, et al. (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63: 1291-1297.
55. Scott A, Weldon S, Buchanan PJ, Schock B, Ernst RK, et al. (2011) Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One 6: e26525.
56. Dzik JM, (2006) Molecules released by helminth parasites involved in host colonization. Acta Biochim Pol 53: 33-64.
57. D'Este F, Tomasinsig L, Skerlavaj B, Zanetti M, (2012) Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-stimulated and-unstimulated macrophages. Immunobiology 217: 962-971.
58. Nakamura S, Morita T, Iwanaga S, Niwa M, Takahashi K, (1977) A sensitive substrate for the clotting enzyme in horseshoe crab hemocytes. J Biochem 81: 1567-1569.
59. Iwanaga S, Morita T, Harada T, Nakamura S, Niwa M, et al. (1978) Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis 7: 183-188.
60. Hochstein HD, (1987) The LAL Test versus the Rabbit Pyrogen Test for endotoxin detection: update '87. Pharma Technol 11: 124-129.
61. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI, (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42: 2206-2214.
62. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, et al. (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68: 2748-2755.
63. Tomasinsig L, De Conti G, Skerlavaj B, Piccinini R, Mazzilli M, et al. (2010) Broad-spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis. Infect Immun 78: 1781-1788.
64. Wang G, Epand RF, Mishra B, Lushnikova T, Thomas VC, et al. (2012) Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37. Antimicrob Agents Chemother 56: 845-856.
65. Nelson A, Hultenby K, Hell E, Riedel HM, Brismar H, et al. (2009) Staphylococcus epidermidis isolated from newborn infants express pilus-like structures and are inhibited by the cathelicidin-derived antimicrobial peptide LL37. Pediatr Res 66: 174-178.
66. Kim SJ, Quan R, Lee SJ, Lee HK, Choi JK, (2009) Antibacterial activity of recombinant hCAP18/LL37 protein secreted from Pichia pastoris. J Microbiol 47: 358-362.
67. Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, et al. (2013) Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 57: 66-73.
68. Oren Z, Shai Y, (1998) Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47: 451-463.
69. Ciornei CD, Sigurdardottir T, Schmidtchen A, Bodelsson M, (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49: 2845-2850.
70. Schroder K, Sweet MJ, Hume DA, (2006) Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
71. Held TK, Weihua X, Yuan L, Kalvakolanu DV, Cross AS, (1999) Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 67: 206-212.
72. Brown KL, Poon GF, Birkenhead D, Pena OM, Falsafi R, et al. (2011) Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol 186: 5497-5505.
73. Sasisekhar B, Aparna M, Augustin DJ, Kaliraj P, Kar SK, et al. (2005) Diminished monocyte function in microfilaremic patients with lymphatic filariasis and its relationship to altered lymphoproliferative responses. Infect Immun 73: 3385-3393.
74. Flynn RJ, Irwin JA, Olivier M, Sekiya M, Dalton JP, et al. (2007) Alternative activation of ruminant macrophages by Fasciola hepatica. Vet Immunol Immunopathol 120: 31-40.
75. Kin NW, Chen Y, Stefanov EK, Gallo RL, Kearney JF, (2011) Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol 41: 3006-3016.
76. Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock RE, (2009) Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J Immunol 183: 5788-5798.
77. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, et al. (2004) Helminth parasites-masters of regulation. Immunol Rev 201: 89-116.
78. van Riet E, Hartgers FC, Yazdanbakhsh M, (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212: 475-490.
79. Jiang Z, Vasil AI, Hale JD, Hancock RE, Vasil ML, et al. (2008) Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers 90: 369-383.
80. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, et al. (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem 280: 12316-12329.
81. Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, et al. (2006) Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J Biol Chem 281: 19861-19871.
82. Porro M, (1994) Structural basis of endotoxin recognition by natural polypeptides. Trends Microbiol 2: 65-66 discussion 66-67.
83. Lynn MA, Kindrachuk J, Marr AK, Jenssen H, Pante N, et al. (2011) Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival. PLoS Negl Trop Dis 5: e1141.
84. Haines LR, Thomas JM, Jackson AM, Eyford BA, Razavi M, et al. (2009) Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Negl Trop Dis 3: e373.
85. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, et al. (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77: 451-459.
86. Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, et al. (1993) Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem 268: 6641-6648.
87. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, et al. (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176: 2455-2464.
88. Nishio N, Ito S, Suzuki H, Isobe K, (2009) Antibodies to wounded tissue enhance cutaneous wound healing. Immunology 128: 369-380.
89. Easton DM, Nijnik A, Mayer ML, Hancock RE, (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27: 582-590.
90. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y, (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 341 (Pt 3) (): 501-513.
91. Risso A, Zanetti M, Gennaro R, (1998) Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol 189: 107-115.
92. Dathe M, Wieprecht T, (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1462: 71-87.
93. Tossi A, Sandri L, Giangaspero A, (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55: 4-30.
94. Kai-Larsen Y, Agerberth B, (2008) The role of the multifunctional peptide LL-37 in host defense. Front Biosci 13: 3760-3767.
95. Vermeire JJ, Cho Y, Lolis E, Bucala R, Cappello M, (2008) Orthologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol 24: 355-363.
96. Prieto-Lafuente L, Gregory WF, Allen JE, Maizels RM, (2009) MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol 85: 844-854.
97. Gomez-Escobar N, Gregory WF, Maizels RM, (2000) Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun 68: 6402-6410.
98. Osman A, Niles EG, LoVerde PT, (2001) Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. J Biol Chem 276: 10072-10082.
99. McSorley HJ, Grainger JR, Harcus Y, Murray J, Nisbet AJ, et al. (2010) daf-7-related TGF-beta homologues from Trichostrongyloid nematodes show contrasting life-cycle expression patterns. Parasitology 137: 159-171.
100. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, et al. (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med 207: 2331-2341.
101. Margis R, Reis EM, Villeret V, (1998) Structural and phylogenetic relationships among plant and animal cystatins. Arch Biochem Biophys 359: 24-30.
102. Gregory WF, Maizels RM, (2008) Cystatins from filarial parasites: evolution, adaptation and function in the host-parasite relationship. Int J Biochem Cell Biol 40: 1389-1398.
103. Dainichi T, Maekawa Y, Ishii K, Zhang T, Nashed BF, et al. (2001) Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response. Infect Immun 69: 7380-7386.
104. Manoury B, Gregory WF, Maizels RM, Watts C, (2001) Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11: 447-451.
105. Schierack P, Lucius R, Sonnenburg B, Schilling K, Hartmann S, (2003) Parasite-specific immunomodulatory functions of filarial cystatin. Infect Immun 71: 2422-2429.
106. Zhu S, (2008) Did cathelicidins, a family of multifunctional host-defense peptides, arise from a cysteine protease inhibitor? Trends Microbiol 16: 353-360.